Assessing the Effects of HbA1c Reduction on Alleviating Nonspecific Back Pain
Status:
Completed
Trial end date:
2023-09-01
Target enrollment:
Participant gender:
Summary
Prediabetes, characterized by elevated HbA1c levels, is a common precursor to type 2 diabetes
mellitus. Recent studies have suggested a potential link between prediabetes and nonspecific
back pain. This randomized controlled trial aimed to assess whether reducing HbA1c levels
through lifestyle interventions and, along with the correction of vitamin D and magnesium,
can alleviate nonspecific back pain in prediabetic patients.